Hyphens Pharma International Limited (SGX:1J5)
Singapore
· Delayed Price · Currency is SGD 0.315
-0.005 (-1.56%)
At close: Mar 9, 2026
SGXC:1J5 Balance Sheet
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 26.83 | 23.42 | 23.37 | 36.48 | 19.46 | Upgrade
|
| Cash & Short-Term Investments | 26.83 | 23.42 | 23.37 | 36.48 | 19.46 | Upgrade
|
| Cash Growth | 14.58% | 0.22% | -35.94% | 87.45% | -29.30% | Upgrade
|
| Accounts Receivable | 33.15 | 43.16 | 39.63 | 30.12 | 27.82 | Upgrade
|
| Other Receivables | 1.1 | 1.56 | 0.75 | 0.39 | 0.3 | Upgrade
|
| Receivables | 34.25 | 44.71 | 40.38 | 30.51 | 28.12 | Upgrade
|
| Inventory | 29.34 | 34.45 | 25.53 | 21.26 | 25.29 | Upgrade
|
| Prepaid Expenses | 4.44 | 2.53 | 2.06 | 0.81 | 0.64 | Upgrade
|
| Other Current Assets | 0.74 | 0.98 | 0.82 | 0.59 | 0.6 | Upgrade
|
| Total Current Assets | 95.6 | 106.09 | 92.15 | 89.65 | 74.11 | Upgrade
|
| Property, Plant & Equipment | 3.87 | 4.9 | 4.86 | 3.02 | 4.41 | Upgrade
|
| Long-Term Investments | - | - | - | 2.67 | 2.31 | Upgrade
|
| Goodwill | 15.4 | 15.4 | 15.4 | 12.81 | 12.81 | Upgrade
|
| Other Intangible Assets | 8.59 | 9.13 | 8.18 | 6.26 | 5.49 | Upgrade
|
| Long-Term Deferred Tax Assets | 0.15 | 0.23 | 0.17 | 0.06 | 0.07 | Upgrade
|
| Total Assets | 123.6 | 135.75 | 120.77 | 114.47 | 99.19 | Upgrade
|
| Accounts Payable | 38.57 | 42.3 | 42.83 | 34.19 | 32.42 | Upgrade
|
| Short-Term Debt | - | 9.01 | - | - | 4.24 | Upgrade
|
| Current Portion of Long-Term Debt | 7.53 | 1.25 | 1.25 | 1.25 | 1.83 | Upgrade
|
| Current Portion of Leases | 1.43 | 1.28 | 1.17 | 1.09 | 1.21 | Upgrade
|
| Current Income Taxes Payable | 2.18 | 2.58 | 2.54 | 2.66 | 1.71 | Upgrade
|
| Other Current Liabilities | - | 1.27 | 1.46 | 0.88 | 1.15 | Upgrade
|
| Total Current Liabilities | 49.71 | 57.69 | 49.24 | 40.07 | 42.56 | Upgrade
|
| Long-Term Debt | - | 0.73 | 1.98 | 3.23 | - | Upgrade
|
| Long-Term Leases | 0.47 | 1.84 | 2.43 | 0.1 | 0.88 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 0.85 | 1.02 | 1.25 | 0.79 | 1.02 | Upgrade
|
| Total Liabilities | 51.03 | 61.28 | 54.9 | 44.2 | 44.46 | Upgrade
|
| Common Stock | 35.22 | 35.22 | 35.22 | 35.08 | 35.08 | Upgrade
|
| Retained Earnings | 43.5 | 45.23 | 37.77 | 43.76 | 34.61 | Upgrade
|
| Treasury Stock | -0.09 | -0.09 | - | - | - | Upgrade
|
| Comprehensive Income & Other | -8.57 | -9.46 | -10 | -9.82 | -14.96 | Upgrade
|
| Total Common Equity | 70.06 | 70.9 | 62.99 | 69.03 | 54.74 | Upgrade
|
| Minority Interest | 2.51 | 3.57 | 2.88 | 1.25 | - | Upgrade
|
| Shareholders' Equity | 72.57 | 74.47 | 65.86 | 70.27 | 54.74 | Upgrade
|
| Total Liabilities & Equity | 123.6 | 135.75 | 120.77 | 114.47 | 99.19 | Upgrade
|
| Total Debt | 9.43 | 14.11 | 6.82 | 5.67 | 8.17 | Upgrade
|
| Net Cash (Debt) | 17.41 | 9.31 | 16.55 | 30.81 | 11.29 | Upgrade
|
| Net Cash Growth | 87.04% | -43.76% | -46.29% | 172.85% | -49.93% | Upgrade
|
| Net Cash Per Share | 0.06 | 0.03 | 0.05 | 0.10 | 0.04 | Upgrade
|
| Filing Date Shares Outstanding | 308.87 | 308.88 | 309.2 | 308.78 | 308.78 | Upgrade
|
| Total Common Shares Outstanding | 308.87 | 308.88 | 309.2 | 308.78 | 308.78 | Upgrade
|
| Working Capital | 45.89 | 48.4 | 42.91 | 49.58 | 31.56 | Upgrade
|
| Book Value Per Share | 0.23 | 0.23 | 0.20 | 0.22 | 0.18 | Upgrade
|
| Tangible Book Value | 46.07 | 46.37 | 39.41 | 49.96 | 36.44 | Upgrade
|
| Tangible Book Value Per Share | 0.15 | 0.15 | 0.13 | 0.16 | 0.12 | Upgrade
|
| Machinery | 9.83 | 11.99 | 10.64 | 10.81 | 10.28 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.